As of Feb 16
| +2.21 / +0.90%|
The 4 analysts offering 12-month price forecasts for Bio Rad Laboratories Inc have a median target of 295.00, with a high estimate of 309.00 and a low estimate of 290.00. The median estimate represents a +18.45% increase from the last price of 249.04.
The current consensus among 4 polled investment analysts is to Buy stock in Bio Rad Laboratories Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.